Company of Biologists ‘Read & Publish’ 1 year Agreement 2021

  • Start: 1 Jan 2021
    Expiry: 31 Dec 2021
  • Description:

    An unlimited Read & Publish Transitional Agreement covering the three Company of Biologists' hybrid journals

Product overview

The Company of Biologists' Read and Publish Transitional Agreement is an all-inclusive product. For a set, annual up-front fee, based on current spend, participating institutions receive unlimited access to all paywalled content, plus unlimited, immediate open access publishing of the Version of Record for all corresponding authors at participating institutions under CC-BY licence terms, in the Society's three hybrid journals.

Development (https://dev.biologists.org)

Cutting-edge research from across the spectrum of animal and plant development and with a clear focus on stem cells, Development is the leading community journal in developmental biology. As well as primary research, it publishes a diverse array of review and hypothesis articles from across the field. Development strives to foster and support the members and the research of the developmental community.

Journal of Cell Science (https://jcs.biologists.org)

Research and reviews that cover the complete range of topics in cell biology. Novel perspectives and approaches to understanding the field. Articles that challenge understanding and stimulate interest. Journal of Cell Science is all about new thinking and scientific excellence in cell biology.

Journal of Experimental Biology (https://jeb.biologists.org)

The leading journal in comparative animal physiology. Journal of Experimental Biology focuses on the form and function of living organisms at all levels of biological organisation - from the molecular and subcellular to the integrated whole animal. Authors and readers reflect a broad interdisciplinary group of scientists who study molecular, cellular and organismal physiology in an evolutionary and environmental context.

Update Type

Information not available.

Update Notes

Information not available.